Cargando…

Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview

Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subty...

Descripción completa

Detalles Bibliográficos
Autores principales: Sikdar, Nilabja, Saha, Gourab, Dutta, Ashmita, Ghosh, Shibajyoti, Shrikhande, Shailesh V., Banerjee, Sudeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128383/
https://www.ncbi.nlm.nih.gov/pubmed/30258276
http://dx.doi.org/10.2174/1389202919666180221160753
_version_ 1783353631512199168
author Sikdar, Nilabja
Saha, Gourab
Dutta, Ashmita
Ghosh, Shibajyoti
Shrikhande, Shailesh V.
Banerjee, Sudeep
author_facet Sikdar, Nilabja
Saha, Gourab
Dutta, Ashmita
Ghosh, Shibajyoti
Shrikhande, Shailesh V.
Banerjee, Sudeep
author_sort Sikdar, Nilabja
collection PubMed
description Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subtypes, pancreatic, Common Bile Duct (CBD), ampullary and duodenum shows relative better prognosis. The highest incidence of PDAC has been reported with black with respect to white population. Similarly, incidence rate of PAC also differs with different ethnic populations. Several lifestyle, environmental and occupational exposures including long-term diabetes, obesity, and smoking, have been linked to PDAC, however, for PAC the causal risk factors were poorly described. It is now clear that PDAC and PAC are a multi-stage process resulting from the accumulation of genomic alterations in the somatic DNA of normal cells as well as inherited mutations. Approximately 10% of PDAC have a familial inheritance. Germline mutations in CDKN2A, BRCA2, STK11, PALB2, PRSS1, etc., as well as certain syndromes have been well associated with predisposition to PDAC. KRAS, CDKN2A, TP53 and SMAD4 are the 4 “mountains” (high-frequency driver genes) which have been known to earliest somatic alterations for PDAC while relatively less frequent in PAC. Our understanding of the molecular carcinogenesis has improved in the last few years due to extensive research on PDAC which was not well explored in case of PAC. The genetic alterations that have been identified in PDAC and different subgroups of PAC are important implications for the development of genetic screening test, early diagnosis, and prognostic genetic markers. The present review will provide a brief overview of the incidence and prevalence of PDAC and PAC, mainly, increased risk in India, the several kinds of risk factors associated with the diseases as well as required genetic alterations for disease initiation and progression.
format Online
Article
Text
id pubmed-6128383
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-61283832019-03-01 Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview Sikdar, Nilabja Saha, Gourab Dutta, Ashmita Ghosh, Shibajyoti Shrikhande, Shailesh V. Banerjee, Sudeep Curr Genomics Article Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subtypes, pancreatic, Common Bile Duct (CBD), ampullary and duodenum shows relative better prognosis. The highest incidence of PDAC has been reported with black with respect to white population. Similarly, incidence rate of PAC also differs with different ethnic populations. Several lifestyle, environmental and occupational exposures including long-term diabetes, obesity, and smoking, have been linked to PDAC, however, for PAC the causal risk factors were poorly described. It is now clear that PDAC and PAC are a multi-stage process resulting from the accumulation of genomic alterations in the somatic DNA of normal cells as well as inherited mutations. Approximately 10% of PDAC have a familial inheritance. Germline mutations in CDKN2A, BRCA2, STK11, PALB2, PRSS1, etc., as well as certain syndromes have been well associated with predisposition to PDAC. KRAS, CDKN2A, TP53 and SMAD4 are the 4 “mountains” (high-frequency driver genes) which have been known to earliest somatic alterations for PDAC while relatively less frequent in PAC. Our understanding of the molecular carcinogenesis has improved in the last few years due to extensive research on PDAC which was not well explored in case of PAC. The genetic alterations that have been identified in PDAC and different subgroups of PAC are important implications for the development of genetic screening test, early diagnosis, and prognostic genetic markers. The present review will provide a brief overview of the incidence and prevalence of PDAC and PAC, mainly, increased risk in India, the several kinds of risk factors associated with the diseases as well as required genetic alterations for disease initiation and progression. Bentham Science Publishers 2018-09 2018-09 /pmc/articles/PMC6128383/ /pubmed/30258276 http://dx.doi.org/10.2174/1389202919666180221160753 Text en © 2018 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Sikdar, Nilabja
Saha, Gourab
Dutta, Ashmita
Ghosh, Shibajyoti
Shrikhande, Shailesh V.
Banerjee, Sudeep
Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
title Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
title_full Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
title_fullStr Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
title_full_unstemmed Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
title_short Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
title_sort genetic alterations of periampullary and pancreatic ductal adenocarcinoma: an overview
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128383/
https://www.ncbi.nlm.nih.gov/pubmed/30258276
http://dx.doi.org/10.2174/1389202919666180221160753
work_keys_str_mv AT sikdarnilabja geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview
AT sahagourab geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview
AT duttaashmita geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview
AT ghoshshibajyoti geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview
AT shrikhandeshaileshv geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview
AT banerjeesudeep geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview